ENTITY
Moderna

Moderna (MRNA US)

109
Analysis
Health Care • United States
Moderna, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
more
Exchange Announcement • 30 Sep 2026 19:15

Current Report (Form 8-K | Period ending 2026-09-30)

Exchange Announcement • 01 Aug 2026 04:17

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 31 Jul 2026 19:03

Current Report (Form 8-K | Period ending 2026-07-31)

Exchange Announcement • 08 Jul 2026 19:08

Current Report (Form 8-K | Period ending 2026-07-06)

Exchange Announcement • 11 May 2026 18:06

Current Report (Form 8-K | Period ending 2026-05-06)

x